| # | Drug | Count |
|---|---|---|
| 0 | ALGLUCOSIDASE ALFA | 18 |
| 1 | AVALGLUCOSIDASE ALFA-NGPT | 16 |
| 2 | AGALSIDASE BETA | 3 |
| 3 | BORTEZOMIB | 1 |
| 4 | METHOTREXATE | 1 |
| 5 | METHOTREXATE SODIUM | 1 |
| 6 | RITUXIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVALGLUCOSIDASE ALFA-NGPT | 16 | 0.0160 |
| 1 | ALGLUCOSIDASE ALFA | 18 | 0.0074 |
| 2 | AGALSIDASE BETA | 3 | 0.0003 |
| 3 | BORTEZOMIB | 1 | 0.0000 |
| 4 | RITUXIMAB | 1 | 0.0000 |
| 5 | METHOTREXATE SODIUM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 34 | 0.0099 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 3 | 0.0003 |
| 2 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |